Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
157.30 x 5 157.70 x 5
Post-market by (Cboe BZX)
157.47 +3.56 (+2.31%) 04/17/25 [NYSE]
157.30 x 5 157.70 x 5
Post-market 157.47 unch (unch) 19:15 ET
Profile for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Johnson & Johnson ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 USA

www.jnj.com Employees: 138,100 P: 732-524-0400

Sector:

Medical

Description:

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 379,478,752
Enterprise Value, $K 386,024,768
Shares Outstanding, K 2,409,848
Annual Sales, $ 88,821 M
Annual Net Income, $ 14,066 M
Last Quarter Sales, $ 22,520 M
Last Quarter Net Income, $ 3,431 M
EBIT, $ 14,023 M
EBITDA, $ 21,362 M
60-Month Beta 0.49
% of Insider Shareholders 0.16%
% of Institutional Shareholders 69.55%
Float, K 2,405,992
% Float 99.84%
Short Volume Ratio 0.45

Growth:

1-Year Return 8.77%
3-Year Return -13.26%
5-Year Return 1.69%
5-Year Revenue Growth 8.24%
5-Year Earnings Growth 14.98%
5-Year Dividend Growth 30.93%

Per-Share Information:

Most Recent Earnings 2.77 on 04/15/25
Next Earnings Date N/A
Earnings Per Share ttm 9.99
EPS Growth vs. Prev Qtr 35.78%
EPS Growth vs. Prev Year 2.21%
Annual Dividend Rate, $ 4.96
Annual Dividend Yield 3.15%
Most Recent Dividend 1.240 on 02/18/25
Next Ex-Dividends Date 05/27/25
Dividend Payable Date 06/10/25
Dividend Payout Ratio 48.76%
Most Recent Split 2-1 on 06/13/01

JNJ Ratios

Ratio
Price/Earnings ttm 15.31
Price/Earnings forward 14.54
Price/Earnings to Growth 2.35
Return-on-Equity % 34.29%
Return-on-Assets % 13.55%
Profit Margin % 15.84%
Debt/Equity 0.43
Price/Sales 4.18
Price/Cash Flow 11.73
Price/Book 5.18
Book Value/Share 29.69
Interest Coverage 23.10

JNJ Dividends

Date Value
02/18/25 $1.2400
11/26/24 $1.2400
08/27/24 $1.2400
05/20/24 $1.2400
02/16/24 $1.1900
11/20/23 $1.1900
08/25/23 $1.1900
05/22/23 $1.1900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro